Guardant360 CDx detects actionable biomarkers
in 55 FDA-approved, clinically relevant genes.1
Detect guideline-recommended genomic biomarkers across all 4 major alteration classes.1
Home Guardant Infinity™ for HCPs Treatment Selection Monitoring and MRD Assessment Guardant Infinity™ for BioPharma
*Reporting is enabled for pathogenic germline alterations only. Somatic alterations will not be reported.¹
†Reporting is enabled for both germline and somatic alterations.¹
Adapted from Guardant360® CDx Technical Information.